BiotechTube
Home/Vertero Therapeutics/A. Stewart Campbell, PhD
AS

A. Stewart Campbell, PhD

Chief Executive Officer

Vertero Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's Disease

Vertero Therapeutics Pipeline

DrugIndicationPhase
VT-5006Parkinson's DiseasePre-clinical

Leadership Team at Vertero Therapeutics

BS
Becca Senter, PhD
Chief Scientific Officer
JK
Jeffrey Kasten
Chief Business Officer
View full Vertero Therapeutics profile